January 29, 2018 by Chain Drug Review
AllianceRx Walgreens Prime, Matt Farber, Rick Miller, specialty pharmacy, Walgreens, Walgreens Connected Care Oncology
Leading Headlines, Pharmacy, Retail News, Technology
DEERFIELD, Ill — Walgreens has received a U.S. patent for new proprietary technology in its Connected Care Oncology specialty pharmacy program. An evidence-based, patient-centered solution, Walgreens Connected Care Oncology focuses on driving medication adherence and improving patient outcomes, and the technology helps guide interactions with patients, helping them to stay on their treatment regimens and manage any
October 25, 2017 by Chain Drug Review
AllianceRx Walgreens Prime, Rite Aid, Stefano Pessina, Walgreens
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) beat Wall Street’s adjusted earnings per share forecast for its 2017 fourth quarter and fiscal year, with pharmacy results helping boost sales for both periods. However, WBA said Wednesday that costs related to the unsuccessful deal to acquire Rite Aid Corp. impacted its bottom line and pulled down
October 23, 2017 by Geoff Walden and Chain Drug Review
Accredo Health Group, AllianceRx Walgreens Prime, CVS Caremark, Express Scripts, Joel Wright, Prime Therapeutics, Walgreens
2017, Issue 10-23-2017, Issues, News
ORLANDO, Fla. — Merging the specialty pharmacy and mail service capabilities of Walgreens and Prime Therapeutics LLC has created a whole that is greater than the sum of its parts, says Joel Wright, chief executive officer of the newly formed AllianceRx Walgreens Prime. Increased purchasing scale and the addition of Prime’s clinical and lives management
October 3, 2017 by Chain Drug Review
AllianceRx Walgreens Prime, Joel Wright, Prime Therapeutics, specialty pharmacy, Walgreens
Featured Articles, Leading Headlines, Pharmacy, Retail News
ORLANDO, Fla. — Walgreens and Prime Therapeutics LLC have inaugurated AllianceRx Walgreens Prime, the brand for the joint central specialty pharmacy and mail services company they formed earlier this year. The companies said the AllianceRx Walgreens Prime launch included the unveiling of new signage at its headquarters in Orlando, Fla., and at other company-owned facilities
April 22, 2017 by Greg Jacobson and Chain Drug Review
Alex Katen, AllianceRx Walgreens Prime, Daniel Tardiff, Don Vidic, Guillermo Sollberger, Jim Adams, Jim DuCharme, Joel Wright, Prime Therapeutics, Walgreens, Walgreens Boots Alliance
2017, Issue 04-24-2017, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) and Prime Therapeutics LLC have completed the formation of a combined central specialty pharmacy and mail service company, a move that was first announced last August. The leadership team of the new enterprise, AllianceRx Walgreens Prime, has also been revealed. Joel Wright, formerly divisional vice president for
April 3, 2017 by Chain Drug Review
AllianceRx Walgreens Prime, Blue Cross and Blue Shield Federal Employee Program, CVS Health, Prime Therapeutics, Walgreens
Business, Pharmacy, Retail News
NEW YORK — Next year, the specialty pharmacy services contract for the Blue Cross and Blue Shield Federal Employee Program (FEP) is slated to pass from CVS Health to Prime Therapeutics LLC. CVS said its specialty pharmacy contract with BCBS FEP will terminate at the end of 2017. Under separate agreements that run through 2018,
April 3, 2017 by Chain Drug Review
AllianceRx Walgreens Prime, Jim DuCharme, Joel Wright, Prime Therapeutics, Walgreens
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill., and ST. PAUL, Minn. — Walgreens and pharmacy benefit manager Prime Therapeutics LLC have completed their transaction to form a joint pharmacy services company and announced its leadership. Called AllianceRx Walgreens Prime and based in Orlando, Fla., the new company melds the central specialty pharmacy and mail service businesses of Walgreens and Prime